Hexagon Capital Partners LLC Amicus Therapeutics, Inc. Transaction History
Hexagon Capital Partners LLC
- $508 Million
- Q3 2024
A detailed history of Hexagon Capital Partners LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Hexagon Capital Partners LLC holds 307 shares of FOLD stock, worth $3,370. This represents 0.0% of its overall portfolio holdings.
Number of Shares
307
Previous 307
-0.0%
Holding current value
$3,370
Previous $3,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding FOLD
# of Institutions
285Shares Held
321MCall Options Held
260KPut Options Held
261K-
Vanguard Group Inc Valley Forge, PA28.6MShares$314 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY28.1MShares$308 Million8.05% of portfolio
-
Avoro Capital Advisors LLC New York, NY27.4MShares$301 Million3.71% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$268 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA21.1MShares$232 Million0.04% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $3.08B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...